Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Verfaillie

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Leukemia|March 31, 1998
Chronic myelogenous leukemia: too much or too little growth, or both?C M Verfaillie
Blood|October 1, 1993
Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiationC M Verfaillie
The Journal of Laboratory and Clinical Medicine|February 1, 1996
Chemokines as inhibitors of hematopoietic progenitorsC M VerFaillie
Acta Clinica Belgica|January 10, 2006
Stem cell research: future implications for internal medicineC M Verfaillie
Hematology/Oncology Clinics of North America|April 2, 1998
Biology of chronic myelogenous leukemiaC M Verfaillie
Stem Cells (Dayton, Ohio)|September 1, 1994
Can human hematopoietic stem cells be cultured ex vivo?C M Verfaillie
Journal of Hematotherapy|April 7, 1999
Chronic myelogenous leukemia: from pathogenesis to therapyC M Verfaillie
Blood|October 9, 1998
Adhesion receptors as regulators of the hematopoietic processC M Verfaillie
Experimental Hematology|April 27, 2000
Meeting report on an NHLBI workshop on ex vivo expansion of stem cells, July 29, 1999, Washington, D.C. National Heart Lung and Blood InstituteC M Verfaillie
Hematology/Oncology Clinics of North America|January 27, 1998
Stem cells in chronic myelogenous leukemiaC M Verfaillie
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Leukemia|March 31, 1998
Chronic myelogenous leukemia: too much or too little growth, or both?C M Verfaillie
Blood|October 1, 1993
Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiationC M Verfaillie
The Journal of Laboratory and Clinical Medicine|February 1, 1996
Chemokines as inhibitors of hematopoietic progenitorsC M VerFaillie
Acta Clinica Belgica|January 10, 2006
Stem cell research: future implications for internal medicineC M Verfaillie
Hematology/Oncology Clinics of North America|April 2, 1998
Biology of chronic myelogenous leukemiaC M Verfaillie
Stem Cells (Dayton, Ohio)|September 1, 1994
Can human hematopoietic stem cells be cultured ex vivo?C M Verfaillie
Journal of Hematotherapy|April 7, 1999
Chronic myelogenous leukemia: from pathogenesis to therapyC M Verfaillie
Blood|October 9, 1998
Adhesion receptors as regulators of the hematopoietic processC M Verfaillie
Experimental Hematology|April 27, 2000
Meeting report on an NHLBI workshop on ex vivo expansion of stem cells, July 29, 1999, Washington, D.C. National Heart Lung and Blood InstituteC M Verfaillie
Hematology/Oncology Clinics of North America|January 27, 1998
Stem cells in chronic myelogenous leukemiaC M Verfaillie
Pageof 9